- Anthony Scaramucci Predicts Invisible Crypto Adoption
- TRADE DESK INC <TTD.O>: TRUIST SECURITIES CUTS TO HOLD FROM BUY; CUTS TARGET PRICE TO $16 FROM $35
- ONTO INNOVATION <ONTO.N>: DEUTSCHE BANK CUTS TARGET PRICE TO $330 FROM $350
- MKS INC. <MKSI.O>: DEUTSCHE BANK RAISES TARGET PRICE TO $385 FROM $360
- INSTACART <CART.O>: DEUTSCHE BANK RAISES TARGET PRICE TO $50 FROM $45
- ETSY <ETSY.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $90 FROM $75
- COREWEAVE <CRWV.O>: DEUTSCHE BANK RAISES TARGET PRICE TO $150 FROM $135
- AIRBNB : DEUTSCHE BANK RAISES TARGET PRICE TO $190 FROM $175
- ENCOMPASS HEALTH <EHC.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $142 FROM $130
- SL GREEN REALTY CORP <SLG.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $65 FROM $55
- KILROY REALTY CORP <KRC.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $37 FROM $33
- WATTS WATER TECHNOLOGIES <WTS.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $389 FROM $372
- TEXAS ROADHOUSE <TXRH.O>: DEUTSCHE BANK RAISES TARGET PRICE TO $234 FROM $212
- RALPH LAUREN <RL.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $446 FROM $441
- SUNRUN <RUN.O>: DEUTSCHE BANK CUTS TARGET PRICE TO $12 FROM $15
- PARKER HANNIFIN : DEUTSCHE BANK RAISES TARGET PRICE TO $998 FROM $896
- GENCO SHIPPING <GNK.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $28 FROM $27
- CLEARWAY ENERGY <CWEN.N>: DEUTSCHE BANK CUTS TARGET PRICE TO $41 FROM $42
- CELSIUS HOLDINGS <CELH.O>: DEUTSCHE BANK CUTS TARGET PRICE TO $30 FROM $39
- MOLSON COORS <TAP.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $43 FROM $41
- MONSTER BEVERAGE CORP. <MNST.O>: DEUTSCHE BANK RAISES TARGET PRICE TO $100 FROM $98
- ONCE UPON A FARM <OFRM.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $20 FROM $17
- FISERV INC <FISV.O>: BMO CUTS TARGET PRICE TO $50 FROM $55
- Canadian Dollar lacks direction ahead of twin US, Canadian employment releases
- Crypto Trends on X in 2026: Regulation, AI, and DeFi Lead Discussions
- Irani Papel e Embalagem declares BRL 0.03/share dividend for Aug. 20 payment
- ANI Pharma investor presentation spotlights Rare Disease shift, targets 2026 net revenue of $1.1 billion
- Embecta Q3 FY26 net income drops 53.6% to $21.1 million; revenue falls 8.1% to $271.7 million
- DOUBLEVERIFY HOLDINGS, INC. <DV.N>: TRUIST SECURITIES CUTS TO HOLD FROM BUY; CUTS TARGET PRICE TO $13.6 FROM $16
- DOXIMITY, INC. <DOCS.N>: BMO RAISES TARGET PRICE TO $30 FROM $20
- CONSTELLATION ENERGY CORP <CEG.O>: BMO RAISES TARGET PRICE TO $379 FROM $376
- ALBEMARLE : BMO CUTS TARGET PRICE TO $200 FROM $250
- Legal & General releases transcript of 2026 half-year results presentation and analyst Q&A
- GENPACT LIMITED <G.N>: BMO RAISES TARGET PRICE TO $40 FROM $34
- McCoy Global Q2 FY26 net earnings drop 92% to $0.1 million; revenue falls 28% to $17.2 million
- PARKER-HANNIFIN CORP : BMO RAISES TARGET PRICE TO $1214 FROM $1068
- Gree hosts FY2026 full-year earnings briefing on Aug. 7, 2026
- Hard Truth for the XRP Army: What Ripple CEO and Monica Long Are Doing
- ITT INC <ITT.N>: BMO RAISES TARGET PRICE TO $273 FROM $266
- Treace Medical Q2 net loss narrows to $15.9 million; revenue falls 4% to $45.4 million
- HUBSPOT, INC. <HUBS.N>: BMO CUTS TO MARKET PERFORM FROM OUTPERFORM; CUTS TARGET PRICE TO $215 FROM $230
- Boundless Bio Q2 FY26 net loss widens to $23.69 million; operating loss widens to $24.38 million
- Pendle Finance adds PT-USDai and PT-sUSDD on Morpho with up to 27% APY
- PREMIUM BRANDS HOLDINGS CORP : BMO CUTS TARGET PRICE TO C$111 FROM C$118
- Exel Composites to host Q2 results briefing online
- Mobility Global Q2 FY26 net income drops 18% to $53 million; revenue rises 7% to $468 million
- Supremex launches NCIB to buy back up to 1,483,187 shares
- Search Minerals closes C$615,000 private placement tranche, upsizes unit financing
- NRx says FDA restarts review of preservative-free ketamine ANDA after vial-cap concern flagged
- Douglas Elliman Q2 FY26 net loss narrows to $2.7 million; revenue rises 4.5% year over year to $283.4 million
- Kimbell Royalty Partners publishes investor deck highlighting 12.7% cash distribution yield, drilling inventory, Q2 records
- LEG Immobilien investor deck spotlights H1 performance, 2026 guidance and balance sheet targets
- Purple Biotech Q2 FY26 net income swings to USD 400,000; operating loss widens to USD 1.3 million
- MAPLEBEAR INC. <CART.O>: BMO RAISES TARGET PRICE TO $65 FROM $60
- HALOZYME THERAPEUTICS, INC. <HALO.O>: LEERINK PARTNERS RAISES TO OUTPERFORM FROM MARKET PERFORM; RAISES TARGET PRICE TO $110 FROM $83
- Elbit Systems director Bar-Nathan Abudi Jacob files initial beneficial ownership statement
- DATADOG INC <DDOG.O>: BMO CUTS TARGET PRICE TO $300 FROM $310
- PAPA JOHN'S INTERNATIONAL INC : BMO CUTS TARGET PRICE TO $30 FROM $42
- Macerich prices upsized USD 675 million exchangeable senior notes offering due 2031
- Ultralife Q2 FY26 GAAP EPS rises to $0.15; revenue falls 1.3% to $47.9 million
- Oklo announces availability of Q2 2026 financial results report and business update
- KLX Energy Services schedules second-quarter earnings conference call
- AEye CEO Matt Fisch joins J.P. Morgan Auto Conference fireside chat
- Rapid Micro Biosystems Q2 FY26 net loss widens to $12.9 million; revenue rises 11% to $8.1 million
- McChip names Zachary Goldenberg CEO after McCloskey resigns
- TRADE DESK INC <TTD.O>: BMO CUTS TO MARKET PERFORM FROM OUTPERFORM; CUTS TARGET PRICE TO $15 FROM $38
- Under Armour Backs FY27 Adj EPS 8c-Adj EPS 12c >UA
- Leonardo says MOST project work advances low- and zero-emission mobility technologies
- FDA flags packaging certification as sole major deficiency for NRx preservative-free ketamine ANDA approval
- TENAZ ENERGY CORP <TNZ.TO>: BMO RAISES TARGET PRICE TO C$75 FROM C$70
- Federal Realty prices USD 400 million exchangeable senior notes offering
- Construction Partners FY26 Q3 net income rises 35% to $59.6 million; revenue increases 28% to $999.4 million
- MICROCHIP TECHNOLOGY <MCHP.O>: BOFA GLOBAL RESEARCH CUTS PRICE OBJECTIVE TO $100 FROM $122
- Vireo Growth wins regulatory approval for PharmaCann Colorado retail asset acquisition
- Aallon Group to release half-year report for January-June 2026
- Johnson Outdoors FY26 Q3 net income rises to USD 14.95 million; net sales increase 5% to USD 189.7 million
- BRIEF-Wendys Q2 Adjusted EPS USD 0.18 Vs. IBES Estimate USD 0.16
- LCI Industries declares quarterly cash dividend of $1.15 a share
- BRIEF-Calumet Q2 EPS USD -1.09
- BRIEF-Rapid Micro Biosystems Q2 EPS USD -0.27
- BRIEF-Johnson Outdoors Q3 EPS USD 1.42
- BRIEF-Kimbell Royalty Partners Q2 Adjusted EBITDA USD 84.907 Million Vs. IBES Estimate USD 75 Million
- BRIEF-Vistra Q2 Revenue USD 4,017 Million Vs. IBES Estimate USD 5,566 Million
- BRIEF-Starz Entertainment Corp Q2 Revenue USD 307.9 Million Vs. IBES Estimate USD 307.5 Million
- BRIEF-Arko Q2 Net Income USD 9.4 Million
- Canopy Growth 1Q Rev C$81.2M >WEED.T
- Canopy Growth 1Q Loss/Shr C$0.03 >WEED.T
- National Healthcare 2Q Adj EPS $1.74 >NHC
- Sylvamo 2Q Adj EPS 3c >SLVM
- Ultralife 2Q Rev $47.9M >ULBI
- Sylvamo 2Q Loss/Shr 28c >SLVM
- Ultralife 2Q Net $2.54M >ULBI
- Under Armour Cuts FY27 View To Loss/Shr 1c-Loss 5c Vs Prior View Breakeven-Loss 4c/Shr >UA
- Under Armour FY27 Revenue Now Expected to Decline at Mid-Single-Digit Percentage Rate Vs Prior Outlook of a Slight Decline >UA
- Under Armour 1Q Accessories Rev Decreased 4% to $96M >UA
- Under Armour 1Q Footwear Rev Declined 8% to $245M >UA
- Under Armour 1Q Apparel Rev Decreased 2% to $734M >UA
- Under Armour 1Q Wholesale Rev Decreased 2% to $638M >UA
- Under Armour 1Q North America Rev Declined 9% to $610M >UA
- Stellantis Consensus Estimates Still Look Vulnerable to Cuts -- Market Talk
